Predictive Value of Serum Inflammatory Markers on Activity of Ulcerative Colitis
小梅马, 2024, Advances in Clinical Medicine CrossRef
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
Bo Chen et al, 2024, Frontiers in Pharmacology CrossRef
Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling
Fan Yang et al, 2021, Frontiers in Immunology CrossRef
Harnessing nature’s pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis
You Huang et al, 2024, Frontiers in Pharmacology CrossRef
Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?
Antonella Smeriglio et al, 2023, Current Medicinal Chemistry CrossRef
The relationship between aflatoxin B1 with the induction of extrinsic/intrinsic pathways of apoptosis and the protective role of taraxasterol in TM3 leydig cell line
Cyrus Jalili et al, 2024, Ecotoxicology and Environmental Safety CrossRef
ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function
Sophie Irwin et al, 2024, Frontiers in Microbiology CrossRef
Pharmacological Action and Research Progress of Taraxasterol
Yu Zhang et al, 2024, Current Pharmaceutical Biotechnology CrossRef
Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation
Ronald Neil Kostoff et al, 2020, World Journal of Gastroenterology CrossRef
Dandelion root extracts and taraxasterol inhibit LPS‑induced colorectal cancer cell viability by blocking TLR4‑NFκB‑driven ACE2 and TMPRSS2 pathways
Kerry Yang et al, 2024, Experimental and Therapeutic Medicine CrossRef
The phytochemical and pharmacological profile of taraxasterol
Fengjuan Jiao et al, 2022, Frontiers in Pharmacology CrossRef